SPAC

Theme · Finance & Investment

Displaying 3 items

Michelle Bell 13 days ago

InMed and Mentari Merge in $421M Deal to Tackle Migraine Treatment Gap

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

Read full article
InMed and Mentari Merge in $421M Deal to Tackle Migraine Treatment Gap
Helen Davis 14 days ago

Iron Dome SPAC's $150M IPO Targets AI & Defense in Maturing Market

The blank-check firm's successful debut signals renewed, selective investor appetite for SPACs with a sharp focus on high-growth Israeli technology.

Read full article
BriefGlance
Carol Thomas Daily about 1 month ago

JATT II Acquisition Corp Raises $60M for AI-Driven Biotech Hunt

With a fresh $60 million IPO, JATT II is targeting the next wave of healthcare innovators using AI and machine learning to revolutionize drug discovery.

Read full article
JATT II Acquisition Corp Raises $60M for AI-Driven Biotech Hunt

Related topics in Finance & Investment

Alternative Investments9Capital Allocation62Debt & Credit Markets2Dividend Strategy21Institutional Investing5IPO & Public Markets10M&A72Private Equity106